ArticleAnnals of the rheumatic diseases2016

Response to: 'Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration' by Marshall et al.

Paul Emery et al.PubMed ↗Publisher ↗

No numbers read from the abstract.